0001209191-16-125860.txt : 20160603 0001209191-16-125860.hdr.sgml : 20160603 20160603210027 ACCESSION NUMBER: 0001209191-16-125860 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bell Graeme CENTRAL INDEX KEY: 0001643757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 161697330 MAIL ADDRESS: STREET 1: 1324 WAVERLY ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-01 0 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001643757 Bell Graeme C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303 0 1 0 0 Executive VP and CFO Common Stock 2016-06-01 4 S 0 751 99.28 D 10255 D This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units. /s/ John C. Duncanson, as attorney-in-fact 2016-06-03